innoviva is focused on bringing compelling new medicines to patients in areas of unmet need by leveraging its significant expertise in the development, commercialization and financial management of bio-pharmaceuticals.

Sector

Professional, Scientific, and Technical Services

Industry

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

CEO

Pavel Raifeld

inva.com/ →

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance

Alerts

News

Golden Cariboo Resources Announces Warrant Repricing and Extension

Beyond Meat Deadline: BYND Investors with Losses in Excess of $100K Have Opportunity to Lead Beyond Meat, Inc. Securities Fraud Lawsuit

Maxim Power Corp. Announces 2025 Fourth Quarter Financial and Operating Results

KD Investors Have Opportunity to Lead Kyndryl Holdings, Inc. Securities Fraud Lawsuit Filed by The Rosen Law Firm

PYPL ALERT: Hagens Berman Alerts PayPal (PYPL) Investors to Securities Class Action Following CEO Ouster and $10B Market Cap Wipeout

BioCardia to Host 2025 Financial Results and Corporate Update Conference Call on March 24, 2026

FedEx Earnings Point to a Leaner, More Competitive Logistics Industry

Soleno Therapeutics (SLNO) Faces Securities Class Action Amid Hyperphagia Drug Launch Disruptions -- Hagens Berman

Nyxoah SA (NYXH) Q4 2025 Earnings Call Transcript

Collegium Pharmaceutical, Inc. (COLL) Discusses Acquisition of AZSTARYS to Expand ADHD Portfolio and Accelerate Growth Transcript

Trip.com Group (TCOM) Shares Crater Amid Questions Over AI Price Adjustment Tool, Anti-Monopoly Regulatory Probe; Securities Class Action Pending -- Hagens Berman

Stocks to Watch as February's PPI Data Comes in Hotter Than Expected

Amazon acquires Rivr, maker of a stair-climbing delivery robot

Unilever in talks to combine food business with McCormick, WSJ reports

FCC approves combination of Nexstar and Tegna TV stations

Understanding Blue Owl's Crash

NMRA Investors Have Opportunity to Join Neumora Therapeutics, Inc. Fraud Investigation with the Schall Law Firm

CORRECTION – Hammond Power Solutions Reports Fourth Quarter 2025 Financial Results

Lifezone Metals Limited (LZM) Q4 2025 Earnings Call Transcript

Tejon Ranch Co. (TRC) Q4 2025 Earnings Call Transcript

About